Neurosigma Congratulates Spanish Team For Their Results In Randomized Controlled Trial Of Etns In Drug Resistant Epilepsy

by prnewswire.com posted 8months ago 184 views
LOS ANGELES, June 24, 2020 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric disorders today announced that results from a randomized...

In this article